Zobrazeno 1 - 10
of 276
pro vyhledávání: '"MacDonald GC"'
Autor:
See, William A.
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations July 2013 31(5):714-714
Autor:
William A. See
Publikováno v:
Urologic oncology. 31(5)
Purpose A phase II study was performed to assess the efficacy and tolerability of intravesical oportuzumab monatox in patients with urothelial carcinoma in situ of the bladder. Bacillus Calmette-Guerin treatment had previously failed in all patients.
Autor:
Boogerd LSF; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., Boonstra MC; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., Prevoo HAJM; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., Handgraaf HJM; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., Kuppen PJK; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., van de Velde CJH; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., Fish A; Netherlands Cancer Institute, Division of Biochemistry, Amsterdam, the Netherlands., Cordfunke RA; Leiden University Medical Centre, Department of Immunohematology and Blood Transfusion, Leiden, the Netherlands., Valentijn ARPM; Leiden University Medical Centre, Department of Clinical Pharmacy and Toxicology, the Netherlands., Terwisscha van Scheltinga AG; Leiden University Medical Centre, Department of Clinical Pharmacy and Toxicology, the Netherlands., MacDonald GC; Viventia Biotechnologies Inc., Winnipeg, MB, Canada., Cizeau J; Viventia Biotechnologies Inc., Winnipeg, MB, Canada., Premsukh A; Viventia Biotechnologies Inc., Winnipeg, MB, Canada., Vinkenburg van Slooten ML; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands., Burggraaf J; Centre for Human Drug Research, Leiden, the Netherlands; Leiden Academic Center for Drug Research, Leiden, the Netherlands., Sier CFM; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands; Antibodies for Research Applications BV, Gouda, the Netherlands., Vahrmeijer AL; Leiden University Medical Centre, Department of Surgery, Leiden, the Netherlands. Electronic address: a.l.vahrmeijer@lumc.nl.
Publikováno v:
Surgical oncology [Surg Oncol] 2019 Mar; Vol. 28, pp. 1-8. Date of Electronic Publication: 2018 Oct 23.
Autor:
Macdonald GC; Diabetes Centre, St Vincent's Hospital, Sydney, New South Wales, Australia. Electronic address: gemma_macdonald28@hotmail.com., Hesselson SE; Diabetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., Chan JY; Diabetes and Metabolism Division, Garvan Institute of Medical Research, NSW, Australia; St Vincent's Clinical School, UNSW Sydney, NSW, Australia., Jenkins AB; School of Medicine, University of Wollongong, Wollongong, Australia., Laybutt DR; Diabetes and Metabolism Division, Garvan Institute of Medical Research, NSW, Australia; St Vincent's Clinical School, UNSW Sydney, NSW, Australia., Hesselson D; Diabetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, UNSW Sydney, Australia. Electronic address: d.hesselson@garvan.org.au., Campbell LV; Diabetes Centre, St Vincent's Hospital, Sydney, New South Wales, Australia; Diabetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, UNSW Sydney, Australia; Department of Endocrinology, St Vincent's Hospital, Sydney, Australia.
Publikováno v:
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2019 Feb; Vol. 148, pp. 64-71. Date of Electronic Publication: 2018 Dec 17.
Autor:
Macdonald GC; Macquarie University, Sydney, Australia gemma.macdonald@svha.org.au.; Diabetes Centre, St Vincent's Hospital, Sydney, Australia., Campbell LV; Diabetes Centre, St Vincent's Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia.
Publikováno v:
Diabetes care [Diabetes Care] 2017 Sep; Vol. 40 (9), pp. e129-e130.
Autor:
Chooniedass S; Viventia Bio Inc., Winnipeg, MB R3T 3Z1, Canada. SChooniedass@viventia.com., Dillon RL; Viventia Bio Inc., Winnipeg, MB R3T 3Z1, Canada. RDillon@viventia.com., Premsukh A; Viventia Bio Inc., Winnipeg, MB R3T 3Z1, Canada. APremsukh@Viventia.com., Hudson PJ; Avipep Pty Ltd., Parkville 3052, Victoria, Australia. Peter.Hudson@avipep.com.au., Adams GP; Eleven Biotherapeutics, Philadelphia, PA 19104, USA. GAdams@viventia.com., MacDonald GC; Eleven Biotherapeutics, Winnipeg, MB R3E 0W3, Canada. glen.macdonald@eleven.com., Cizeau J; Viventia Bio Inc., Winnipeg, MB R3T 3Z1, Canada. JCizeau@viventia.com.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2016 Dec 17; Vol. 21 (12). Date of Electronic Publication: 2016 Dec 17.
Autor:
Mai, Yansui1 (AUTHOR), Su, Jiyan1 (AUTHOR), Yang, Chuan2 (AUTHOR), Xia, Chenglai1 (AUTHOR) xiachenglai@smu.edu.cn, Fu, Liwu2 (AUTHOR) Fulw@mail.sysu.edu.cn
Publikováno v:
Molecular Cancer. 11/23/2023, Vol. 22 Issue 1, p1-24. 24p.
Autor:
Omolara, Abiodun Esther1 (AUTHOR), Alawida, Moatsum2 (AUTHOR), Abiodun, Oludare Isaac1 (AUTHOR) oludare.abiodun@uniabuja.edu.ng
Publikováno v:
Neural Computing & Applications. Nov2023, Vol. 35 Issue 31, p23063-23101. 39p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Macdonald GC; Diabetes Centre, St Vincent's Hospital, Sydney, NSW 2010, Australia. Electronic address: gemma.macdonald@svha.org.au., Campbell LV; Diabetes Centre, St Vincent's Hospital, Sydney, NSW 2010, Australia.
Publikováno v:
Lancet (London, England) [Lancet] 2016 Aug 06; Vol. 388 (10044), pp. 561.